Tag: hyperkalaemia
AccurKardia announces clinical pilot study of ECG-based, AI-powered hyperkalaemia detection software
AccurKardia has announced the initiation of a multicentre clinical pilot study of AK+ Guard—a US Food and Drug Administration (FDA) Breakthrough Device designated, artificial...
European Commission grants marketing authorisation to Vifor for patiromer hyperkalaemia treatment
The European Commission has granted marketing authorisation for sodium-free potassium binder, patiromer (Valtessa; Vifor Fresenius Medical Care Renal Pharma, Vifor UK), for the treatment...

